CENTER ID: | ChtrB.19237.a |
ORGANISM: | Chlamydia trachomatis D/UW-3/Cx |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | in PDB |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
non-BEI |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
ChtrB.19237.a.B1.GE42731 | full length | 1 | 124 | ||
ChtrB.19237.a.B11.GE42732 | full length | 1 | 124 | ||
ChtrB.19237.a.B12.GE42733 | full length | 1 | 124 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
ChtrB.19237.a.B1.PW38581 | full length | 1 | 124 | ||
ChtrB.19237.a.B1.PW39240 | full length | 1 | 124 |
RESOURCE | REFERENCE ID |
---|---|
PATRIC ID: | fig|272561.5.peg.438 |
UniProt: | O84412 |
HARVESTED ON: | 11/5/2018 |
SEQUENCED ON: | 11/7/2018 |
EXPECTED MW: | 15kDa |
OBSERVED MW: | 15kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
HARVESTED ON: | 11/5/2018 |
SEQUENCED ON: | 11/7/2018 |
EXPECTED MW: | 15kDa |
OBSERVED MW: | 15kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
HARVESTED ON: | 11/5/2018 |
SEQUENCED ON: | 11/7/2018 |
EXPECTED MW: | 15kDa |
OBSERVED MW: | 15kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 12/17/2018 |
CONCENTRATION: | 24.61mg/ml |
OBSERVED MW: | 17kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 11 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
PURIFICATION DATe: | 11/27/2023 |
CONCENTRATION: | 19.2mg/ml |
OBSERVED MW: | 15kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 23 |
VIAL VOLUME: | 110µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |